During the past decade, Regionalspital conducted 26 clinical trials. In the 10-year time frame, 26 clinical trials started and 8 clinical trials were completed, i.e. on average, 30.8% percent of trials that started reached the finish line to date. In the past 5 years, 7 clinical trials started and 3 clinical trials were completed. i.e. 42.9% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Regionalspital" #1 sponsor was "Swiss Group for Clinical Cancer Research" with 46 trials, followed by "ETOP IBCSG Partners Foundation" with 7 trials sponsored, "Queen Mary University of London" with 2 trials sponsored, "Bern University of Applied Sciences" with 1 trials sponsored and "German CLL Study Group" with 1 trials sponsored. Other sponsors include 2 different institutions and companies that sponsored additional 12 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Regionalspital" #1 collaborator was "Breast International Group" with 2 trials as a collaborator, "Cantonal Hospital of St. Gallen" with 2 trials as a collaborator, "National Cancer Institute (NCI)" with 2 trials as a collaborator, "Spital STS AG" with 2 trials as a collaborator and "University Hospital Inselspital, Berne" with 2 trials as a collaborator. Other collaborators include 58 different institutions and companies that were collaborators in the rest 68 trials.

According to Clinical.Site data, the most researched conditions in "Regionalspital" are "Breast Cancer" (18 trials), "Lung Cancer" (6 trials), "Colorectal Cancer" (4 trials), "Lymphoma" (4 trials) and "Prostate Cancer" (4 trials). Many other conditions were trialed in "Regionalspital" in a lesser frequency.

Most popular intervention types in "Regionalspital" are "Drug" (50 trials), "Radiation" (11 trials), "Biological" (10 trials), "Other" (9 trials) and "Procedure" (9 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (5 trials), "Radiotherapy" (5 trials), "Dexamethasone" (3 trials), "Durvalumab" (3 trials) and "Ibrutinib" (3 trials). Other intervention names were less common.

The vast majority of trials in "Regionalspital" are 40 trials for "All" genders, 18 trials for "Female" genders and 6 trials for "Male" genders.

Currently, there are NaN active trials in "Regionalspital". undefined are not yet recruiting, 2 are recruiting, 17 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 32 completed trials in Regionalspital, undefined suspended trials, and 12 terminated clinical trials to date.

Out of the total trials that were conducted in Regionalspital, 2 "Phase 1" clinical trials were conducted, 30 "Phase 2" clinical trials and 24 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 8 trials that are defined as “Not Applicable".

Regionalspital has several departments that took part in Clinical trials: "Onkologiezentrum Berner Oberland" - 5 trials